Therefore, the routine assessment of sarcopenia can help in identifying patients who may benefit from treatment with ICIs and those at high risk of disease progression, and it is highly significant for guiding clinical treatment.
← all excerpts
Progress in Research on Antitumor Drugs and Dynamic Changes in Skeletal Muscles.
1
—
—